Skip to main content
Top
Published in: International Urology and Nephrology 5/2013

01-10-2013 | Urology - Original Paper

Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures

Authors: Chi-Fai Ng, Peter K. F. Chiu, Miu-Ling Li, Chi-Wai Man, Simon S. M. Hou, Eddie S. Y. Chan, Peggy S. K. Chu

Published in: International Urology and Nephrology | Issue 5/2013

Login to get access

Abstract

Objective

To evaluate the outcomes of augmentation cystoplasty in patients with bladder contractures secondary to chronic ketamine abuse.

Method

Patients who had received augmentation cystoplasty to treat ketamine-related bladder contractures in two hospitals in our region were reviewed retrospectively. Their history of ketamine consumption, presenting symptoms, history of treatment, surgical information and post-operative conditions were retrieved from clinical records and then summarized.

Results

Between 2006 and 2011, four patients (three women and one man), aged 21–30 years (mean 27 years), underwent augmentation cystoplasty for ketamine-related bladder contractures. The duration of ketamine consumption ranged from 3 to 15 years, and all four patients resumed ketamine consumption after surgery. The mean maximal baseline and post-operative bladder capacity was 37.5 cc (range 25–50 cc) and up to 400–500 cc, respectively. Three patients experienced a further deterioration in renal function that was secondary to new-onset ureteral strictures in two cases and to sepsis in the other. At the time of the last follow-up, three patients could void spontaneously and one required regular intermittent catheterization.

Conclusion

Ketamine cystitis is an emerging medical condition that requires a multi-disciplinary approach to manage the patients. Simple surgical management of the physical component of the contracted bladder may produce only suboptimal results, and could even cause further problems in some patients. The importance of compliance with post-operative care and abstinence from drug use should be stressed to the patients before surgery. In view of the high complication rate, the option of a simple ileal conduit should also be discussed prior to surgical intervention.
Literature
1.
go back to reference Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107–7116 Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107–7116
2.
go back to reference Wolff K (2012) Ketamine. In: Verster JC et al (eds) Drug abuse and addiction in medical illness: causes, consequences and treatment. Springer, New York, pp 201–211CrossRef Wolff K (2012) Ketamine. In: Verster JC et al (eds) Drug abuse and addiction in medical illness: causes, consequences and treatment. Springer, New York, pp 201–211CrossRef
3.
go back to reference Froster JA, Harrison SCW (2012) Ketamine uropathy: rising to the challenges of a new condition. BJU Int 109:1277–1278CrossRef Froster JA, Harrison SCW (2012) Ketamine uropathy: rising to the challenges of a new condition. BJU Int 109:1277–1278CrossRef
4.
go back to reference Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110:1762–1766PubMedCrossRef Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110:1762–1766PubMedCrossRef
5.
go back to reference Lin M (2004) The underappreciated dangers of “club drugs”: what clinicians need to know. Adv Stud Med 4:191–198 Lin M (2004) The underappreciated dangers of “club drugs”: what clinicians need to know. Adv Stud Med 4:191–198
6.
go back to reference Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69:810–812PubMedCrossRef Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69:810–812PubMedCrossRef
7.
go back to reference Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, Tse ML, Lau FL (2007) ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311–313PubMed Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, Tse ML, Lau FL (2007) ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311–313PubMed
8.
go back to reference Middela S, Pearce I (2011) Ketamine-induced vesiculopathy: a literature review. Int J Clin Pract 65:27–30PubMedCrossRef Middela S, Pearce I (2011) Ketamine-induced vesiculopathy: a literature review. Int J Clin Pract 65:27–30PubMedCrossRef
9.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef
10.
go back to reference Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JML, Lau FL, Yiu MK, Man CW (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616–1622PubMedCrossRef Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JML, Lau FL, Yiu MK, Man CW (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616–1622PubMedCrossRef
11.
go back to reference Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280–1293PubMedCrossRef Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280–1293PubMedCrossRef
12.
go back to reference Stein R, Schröder A, Thüroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153–161PubMedCrossRef Stein R, Schröder A, Thüroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153–161PubMedCrossRef
13.
go back to reference Stein R, Kamal MM, Rubenwolf P, Ziesel C, Schröder A, Thüroff JW (2012) Bladder augmentation using bowel segments (enterocystoplasty). BJU Int 110:1078–1094PubMedCrossRef Stein R, Kamal MM, Rubenwolf P, Ziesel C, Schröder A, Thüroff JW (2012) Bladder augmentation using bowel segments (enterocystoplasty). BJU Int 110:1078–1094PubMedCrossRef
15.
go back to reference Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376–382PubMedCrossRef Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376–382PubMedCrossRef
16.
go back to reference Blonk MI, Koder BG, van den Bemt PM, Huygen FJ (2010) Use of oral ketamine in chronic pain management: a review. Eur J Pain 14:466–472PubMedCrossRef Blonk MI, Koder BG, van den Bemt PM, Huygen FJ (2010) Use of oral ketamine in chronic pain management: a review. Eur J Pain 14:466–472PubMedCrossRef
18.
go back to reference DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef
19.
go back to reference Tabor PA, Lopez DA (2004) Comply with us: improving medication adherence. J Pharm Pract 17:167–180CrossRef Tabor PA, Lopez DA (2004) Comply with us: improving medication adherence. J Pharm Pract 17:167–180CrossRef
20.
go back to reference Lucas GM (2011) Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sci 88:948–952PubMedCrossRef Lucas GM (2011) Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sci 88:948–952PubMedCrossRef
Metadata
Title
Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures
Authors
Chi-Fai Ng
Peter K. F. Chiu
Miu-Ling Li
Chi-Wai Man
Simon S. M. Hou
Eddie S. Y. Chan
Peggy S. K. Chu
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0501-4

Other articles of this Issue 5/2013

International Urology and Nephrology 5/2013 Go to the issue